Skip to main content
OpenTrials

Clinical trial condition

RNA Virus Infections

Explore clinical trials studying RNA Virus Infections. Study availability and eligibility vary by location and protocol.

15,765 public trials 830 recruiting studies
Refine in advanced search Browse all conditions

RNA Virus Infections trial results

Completed

Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Children

NCT04816643

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
Locations
  • University of Alabama at Birmingham - School of Medicine Birmingham, Alabama, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • SCPMG/Kaiser Permanente Los Angeles Medical Center Los Angeles, California, United States
  • Matrix Clinical Research Los Angeles, California, United States
View all 128 locations
View Trial Details
Completed

A Study to Assess the Immune Response and Safety of a Vaccine Against Influenza in Adults 18 Years of Age and Older

NCT07121192

Conditions
Infections, Influenza, Human, Orthomyxoviridae Infections, +4 more
Locations
  • GSK Investigational Site Anniston, Alabama, United States
  • GSK Investigational Site Fair Oaks, California, United States
  • GSK Investigational Site San Diego, California, United States
  • GSK Investigational Site San Diego, California, United States
View all 22 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy, Safety, Participant Choice and Preference of an Oral Once-daily Regimen or a Long-acting Injectable Regimen Every Two Months for Treatment of Human Immunodeficiency Virus (HIV-1) in Adults Who Have Not Previously Taken Antiretroviral Therapy

NCT05917509

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Bakersfield, California, United States
  • GSK Investigational Site Fort Lauderdale, Florida, United States
  • GSK Investigational Site Ft. Pierce, Florida, United States
View all 47 locations
View Trial Details
Completed

Study of Oral TLR8 Agonist Selgantolimod on HBsAg in Participants With Both Chronic Hepatitis B and HIV

NCT05551273

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +18 more
Locations
  • UCSD Antiviral Research Center CRS (Site 701) San Diego, California, United States
  • The Ponce de Leon Center CRS (Site 5802) Atlanta, Georgia, United States
  • Weill Cornell Chelsea CRS (Site 7804) New York, United States
  • Greensboro CRS (Site# 3203) Greensboro, North Carolina, United States
View Trial Details

Related conditions